<DOC>
	<DOCNO>NCT00551876</DOCNO>
	<brief_summary>The purpose study determine addition ezetimibe 10 mg daily ongoing 20 mg simvastatin daily reduce LDL Cholesterol great extent increase dose simvastatin 40 mg daily Type 2 diabetic treat Thiazolidinediones ( TZD ) .</brief_summary>
	<brief_title>Study Evaluating Efficacy Safety Simvastatin Alone Compared With Simvastatin Plus Ezetimibe Type 2 Diabetic Patients ( 0653-021 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Men woman age 30 75 Type 2 diabetes mellitus treat pioglitazone rosiglitazone Additionally , patient must LDLC &gt; 100 mg/dL Visit 1 prior initiation statin therapy Patients take slide scale insulin , select lipid lower medication , oral anticoagulant cyclical sex hormone Patients heart disease , kidney disease , liver disease , uncontrolled high blood pressure , insulin dependent diabetes</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>